Company

• Overview

• Board of Directors

• Partnering

• Core competence

Technology

• Bispecific

• Proprietary ADC Platform

• Mix-mAb

• Publications

Pipeline

• Overview

• Envafolimab(KN035)

• KN046

• KN026

• JSKN003

• KN026+KN046

• KN019

• KN052

Investors

• Information Disclosure

• Corporate Governance

• Stock Information

• IR Contacts

• Email Subscription

News

• Press Release

• Media Report

Career

• Corporate Culture

• Job Opportunities

Contact Us